Pharmaceutical Technology

AUGUST 12, 2022

Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects.

Development 130

Development Drug Delivery Systems Drug Delivery Clinical Trials 130

Camargo

NOVEMBER 24, 2020

Why is pulmonary drug delivery a complex challenge? Pulmonary delivery is highly specialized, and despite our vast and growing understanding of respiratory diseases and aerosol technologies, developing new and improved inhaled medicines still presents a number of challenges, particularly in getting the drug delivered to its target.

Drug Delivery 130

Drug Delivery Drugs Allergies Medicine 130

BioPharma Reporter

DECEMBER 13, 2021

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

Antibody 143

Antibody Clinical Trials Clinical Trials Clinical Development 143

VirTrial

OCTOBER 9, 2020

The partnership will enable BetterLife to conduct remote patient monitoring for their imminent COVID 19 clinical trials in Australia to test the efficacy of AP-003, a proprietary interferon alpha 2b formulation. . (CSE: BETR / OTCQB: BETRF) as their telehealth platform provider of choice. About VirTrial. About BetterLife Pharma Inc.:

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

OCTOBER 27, 2021

Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.

Drug Delivery Systems 104

Drug Delivery Systems Drug Delivery FDA Approval Drugs 104

Drug Discovery World

JANUARY 12, 2023

Here, Thomas reflects specifically on Anita Cooper’s prediction relating to the importance of clinical trials. . Following the launch of Protas, DDW spoke with Protas Chief Executive, Professor Sir Martin Landray, who echoed Cooper’s emphasis on the importance of clinical trial design.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

Roots Analysis

FEBRUARY 14, 2023

Presently, outsourcing of liposomes development and manufacturing related services has become a popular practice. Drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52

Pharmaceutical Technology

FEBRUARY 27, 2023

Hydrocortisone is under clinical development by Antares Pharma and currently in Phase I for Adrenal Insufficiency. According to GlobalData, Phase I drugs for Adrenal Insufficiency have a 67% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. It is administered by parenteral route.

Drug Delivery 100

Drug Delivery Drug Delivery Systems Production Drugs 100

Drug Discovery World

FEBRUARY 5, 2024

EXO Biologics has launched ExoXpert, a contract development and manufacturing organisation (CDMO) specialising in exosomes which offers a mesenchymal stem cells (MSC)-based exosome manufacturing platform used in European clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing Gene Therapy 52

XTalks

AUGUST 30, 2022

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. CNS drugs treat a range of neurologic and psychiatric disorders, such as psychosis, depression, Parkinson’s disease, multiple sclerosis and epilepsy.

Trials 83

Trials Drug Delivery Drugs Gene 83

pharmaphorum

MARCH 15, 2022

Sanofi has agreed a deal with life sciences investor Blackstone to help fund clinical trials of a new formulation of Sarclisa for blood cancer multiple myeloma, accelerating its development. Sanofi has partnered with drug delivery specialist Enable Injections to develop the subcutaneous formulation.

Trials 92

Trials Sales Drug Delivery Antibody 92

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Drug Discovery World

FEBRUARY 5, 2024

Utilising our integrated experimental biology and machine learning platform to realise the power of large-scale, systemic data, we are developing a preclinical pipeline of targeted oncology therapeutics in biomarker-defined settings — reinventing the traditional approach to target and drug discovery.

Research 116

Research Drug Delivery Systems Gene Sequencing Trials 116

Pharmaceutical Technology

MAY 31, 2023

Decoy-20 is under clinical development by Indaptus Therapeutics and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase I drugs for Hepatocellular Carcinoma have an 81% phase transition success rate (PTSR) indication benchmark for progressing into Phase II.

Drug Delivery Systems 130

Drug Delivery Systems Drug Delivery Bacteria Drugs 130

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

pharmaphorum

JULY 15, 2022

SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data. Drug delivery will also be an important aspect of the agenda, with advancements in novel technologies. And many more!

Gene Therapy 52

Gene Therapy Drugs Drug Delivery Clinical Trials 52

Drug Discovery World

AUGUST 4, 2022

However, starting early can greatly improve the efficiency and speed of the development process. This is especially true now, with the rise of drug-device combination products that demand sophisticated delivery systems. The increasing complexity of drug products has raised concern among pharmaceutical developers.

Containment 52

Containment Development Drugs Production 52

Drug Discovery World

AUGUST 19, 2022

Respira is currently developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases. The company is in the midst of securing financing for clinical trials. Respira’s founder, Mario Danek, will transition to the role of Chief Technology Officer (CTO).

Drug Delivery 52

Drug Delivery Clinical Trials Clinical Trials Production 52

Pharmaceutical Technology

APRIL 4, 2023

The company will undertake a technology transfer and feasibility study for a drug product focused on the treatment of IPF at its centre of cell and gene expertise in Milan, Italy. Pre-clinical trials may begin later in 2023, if the feasibility study is successful. These vesicles are extracted from a bronchial epithelial cell.

Gene Therapy 130

Gene Therapy Gene Drug Delivery Medicine 130

Roots Analysis

MARCH 2, 2022

Interestingly, recent advances in this domain have led to the development of several treatment strategies that, according to developers, exhibit the necessary capabilities to overcome challenges posed by traditional oral protein formulations and peptide-based therapies. Oral Protein / Peptide-based Drugs.

Protein 52

Protein Drug Delivery Drugs Drug Delivery Systems 52

pharmaphorum

NOVEMBER 7, 2022

The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. The conference is co-chaired by Mitchell A.

Drugs 52

Drugs Clinical Trials Clinical Trials Gene Therapy 52

XTalks

JUNE 14, 2023

The clinical trials consistently showed significant therapeutic improvements in ocular surface damage and associated symptoms, while pioneering visual function improvement analysis”, said John D. “The Attendees will understand best practices for novel drug delivery design and development. What Is Dry Eye Disease?

Gene Silencing 97

Gene Silencing Drug Delivery FDA Approval RNA 97

pharmaphorum

OCTOBER 18, 2022

“Connected drug delivery devices play an important role in helping biopharmaceutical manufacturers understand and track key trends in patient adherence,” said Matthew Schabacker, general manager of BD’s advanced drug delivery unit.

Drug Delivery 52

Drug Delivery Manufacturing Drugs Marketing 52

Roots Analysis

MARCH 16, 2022

In order to promote the use of exosomes in various therapeutic applications including targeted drug delivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Broad Clinical Trial Landscape.

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

The Pharma Data

SEPTEMBER 11, 2020

This week’s round up dives into developments from companies based in Australia and the US. Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ? Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

The Pharma Data

DECEMBER 27, 2020

In these unprecedented times, we are especially grateful for the dedication of our research site staff and trial participants, whose commitment to EXCELLENCE facilitated the advancement of our lead program,” said George Yeh, President of TLC. “We SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40

XTalks

MAY 30, 2023

The VTT Technical Research Centre of Finland has addressed this issue by developing a fully recyclable, modular ECG patch constructed from VTT’s novel cellulose e-skin material. There are also several ECG patches currently in clinical trials that could soon enter the market.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

XTalks

JUNE 15, 2022

Royal Philips has been researching and developing treatment for critical limb ischemia. In 2018, the commpany announced the Stellarex 0.014″ Drug-Coated Balloon for below-the-knee PTA. These results were collected from a three-year follow-up in the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

NOVEMBER 25, 2022

There are clearly challenges to developing a drug targeting a rare disease, due to the small and often undiagnosed populations, and these challenges are also present when developing an accurate forecast of their market potential. Data and market insights. Case study: severe asthma. Scenario planning and forecasting.

Marketing 120

Marketing Clinical Trials Clinical Trials Production 120

pharmaphorum

MAY 26, 2021

per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 Vectura has agreed to a £1.55 billion). . ” Investors seemed to share that view, as shares in Vectura leaped by almost a third after the announcement.

Drug Delivery 62

Drug Delivery Sales Drugs Clinical Trials 62

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. These include broad-spectrum sunscreens, protective clothing and innovative skincare products developed using antioxidants and other protective agents. How is Medicus Pharma innovating in this space?

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

The Pharma Data

JANUARY 31, 2021

(CSI ® ) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This collaboration enables us to develop a new class of DCBs that we believe will improve patient outcomes.”. Cardiovascular Systems, Inc.,

Development 52

Development Drugs Production Containment 52

Drug Discovery World

JUNE 7, 2023

pHion is developing a pipeline of therapeutic and prophylactic vaccines focussed on oncology and infectious diseases. Infection with HPV is responsible for approximately 90% of cervical cancers and up to 70% of oropharyngeal cancers, with a high unmet clinical need.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

BioSpace

NOVEMBER 17, 2022

Editas Medicine is pausing its ocular gene therapy program after demonstrating a favorable safety profile and seeking a potential partner to develop EDIT-101, the company announced Thursday.

Gene Therapy 42

Gene Therapy Gene Gene Editing Medicine 42

Roots Analysis

FEBRUARY 18, 2022

The key focus of these studies is on the development of anti-tumor therapeutics. CLINICAL TRIALS EVALUATING MYELOID CELLS TAREGTING THERAPEUTICS. In the past decade, more than 1,500 clinical trials have been registered for evaluating drug therapies targeting myeloid cells. Our Social Media Platform.

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Pharmaceutical Technology

NOVEMBER 7, 2022

SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. The Charleston Regional Development Alliance (CRDA) is supporting SHL Medical by facilitating valuable connections to best-in-class service providers in the area.

Production 130

Production Life Science Manufacturing Drug Delivery Systems 130

Drug Discovery World

JANUARY 19, 2023

They are called “ Innovation, investment and commitment: Genentech’s approach to the future of ophthalmology ” and “ Innovative delivery of sustained ophthalmic steroids for high unmet needs in diabetic macular edema ”. You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Drug Delivery 52

Drug Delivery Drugs Medicine Development 52